Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul H. Klingenstein
AddedMar 31, 2024
UpdatedMay 31, 2026
Paul H. Klingenstein

Paul H. Klingenstein

Board Member, John D & Catherine T Mac Arthur Foundation

Crunchbase

Paul H. Klingenstein's Career

John D & Catherine T Mac Arthur Foundation
John D & Catherine T Mac Arthur Foundation

Chicago, IL, US

Board Member· Board
Clovis Oncology
Clovis Oncology

Boulder, CO, US

Board Member· Board
Aviir
Aviir

Irvine, CA, US

Board Member· Board
MC10
MC10

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul H. Klingenstein's Career

John D & Catherine T Mac Arthur Foundation
John D & Catherine T Mac Arthur Foundation
NonprofitNonprofit2731978Chicago, IL, US
Board Member· Board

Leadership at John D & Catherine T Mac Arthur Foundation

Martha L. MinowMartha L. MinowBoard Member
James ManyikaJames ManyikaBoard Member
John D. MacArthurJohn D. MacArthurCo-Founder
Catherine T. MacArthurCatherine T. MacArthurCo-Founder
Clovis Oncology
Clovis Oncology
Public$145M4132009Boulder, CO, US
Board Member· Board

Leadership at Clovis Oncology

Rick FairRick FairBoard Member
Bob AzelbyBob AzelbyBoard Member
Jim BlairJim BlairBoard Member
Patrick J. MahaffyPatrick J. MahaffyFounder
Brian AtwoodBrian AtwoodBoard Member
Aviir
Aviir
Series B$69.9M752005Irvine, CA, US
Board Member· Board

Leadership at Aviir

Douglas HarringtonDouglas HarringtonCEO
Bill GerberBill GerberBoard Member
Vijay LathiVijay LathiBoard Member

Similar to Aviir

AvicenaAvicenaPasadena, CA, USMedical Devicesest. 2014AvicenaPasadena, CA, US · est. 2014

Avicena: Innovating cardiovascular health with advanced medical devices and algorithms.

Pre-Seed · $2.5M24
Arterial Health InternationalArterial Health InternationalAtlanta, GA, USDiagnostic Testsest. 2009Arterial Health InternationalAtlanta, GA, US · est. 2009

Arterial Health International, LLC® offers comprehensive diagnostic tests for early detection of Cardiovascular Disease risk factors.

Seed · $90k30
Akrivis TechnologiesAkrivis TechnologiesCambridge, MA, USDiagnostics, Research Kitsest. 2009Akrivis TechnologiesCambridge, MA, US · est. 2009

Akrivis Technologies: A biopharmaceutical firm offering early detection services, research kits, and more.

Angel · $674.7k2
CardiovipCardiovipSugar Land, TX, USDiagnostics, Heart Healthest. 2010CardiovipSugar Land, TX, US · est. 2010

CardioVIP: A pioneering heart health program combining imaging and blood tests for comprehensive cardiovascular care.

Series A · $5.8M7
MC10
MC10
Series A$97.4M382008Cambridge, MA, US
Board Member· Board

Leadership at MC10

Roozbeh GhaffariRoozbeh GhaffariCo-Founder
Gilman CallsenGilman CallsenCo-Founder
Adam FineAdam FineBoard Member
Jiong MaJiong MaBoard Member
Carmichael RobertsCarmichael RobertsBoard Member
George WhitesidesGeorge WhitesidesCo-Founder

Paul H. Klingenstein's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Paul H. Klingenstein

Margaret McGlynnMargaret McGlynnBoard Member · Amicus TherapeuticsPaul JenkinsonPaul JenkinsonBoard Member · Aivita BiomedicalSteve PaulSteve PaulBoard Member · Voyager TherapeuticsBruno StriginiBruno StriginiBoard Member · OwkinNick NaclerioNick NaclerioFounder · Illumina VenturesCaley CasteleinCaley CasteleinFounder · Kearny Venture Partners